Lightstone Ventures

Portfolio Co Investors 2026 for Lightstone Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Lightstone Ventures accounts for 23 tracked companies with verified cap-table data, 23 of which disclose round sizes totalling $3B. The median disclosed raise is $100M, and the largest is Nimbus Therapeutics at $600M, ahead of FIRE1 ($213M) and Apreo Health ($212M).

The names that recur most often on these co-invested cap tables are Lightstone Ventures (23 companies), Endeavour Vision (3 companies), Gilde Healthcare (3 companies), New Enterprise Associates (3 companies), SR One (2 companies), Bill Gates (2 companies). By latest disclosed round, the market skews Series B (9), Series A (8), Series C (3), Series D (1).

Best funded Lightstone Ventures companies

  1. Nimbus Therapeutics — $600M (latest: Series B)
  2. FIRE1 — $213M (latest: Series B)
  3. Apreo Health — $212M (latest: Series B)
  4. Crystalys Therapeutics — $205M (latest: Series A)
  5. Cerevance — $204M (latest: Series B)
  6. Willow — $155M (latest: Series C)
  7. Locanabio — $155M (latest: Series B)
  8. Nuvaira — $145M
  9. Cyteir Therapeutics — $140M (latest: Series C)
  10. ProVerum Medical — $114M (latest: Series B)
  11. Reprieve Cardiovascular — $103M (latest: Series B)
  12. Amber Therapeutics — $100M (latest: Series A)
  13. Trinity College, Dublin — $80M (latest: Series B)
  14. Catabasis Pharmaceuticals — $72M (latest: Series B)
  15. Relievant Medsystems — $70M

Lightstone Ventures — related firms and companies (56)

Lightstone Ventures profile · All research reports